Valuation: Biosenta Inc.

Market Cap 2.21M 1.6M 1.37M 1.28M 1.18M 154M 2.25M 15.12M 5.91M 77.05M 6.02M 5.89M 254M P/E 2024
-1.19x
P/E 2025 -1.59x
Enterprise Value 8.82M 6.38M 5.47M 5.09M 4.7M 612M 8.97M 60.23M 23.55M 307M 23.99M 23.47M 1.01B EV / Sales 2024
6,101x
EV / Sales 2025 8,809x
Free-Float
88.05%
Yield 2024 *
-
Yield 2025 -
1 week-20.00%
Current month+71.43%
1 month+20.00%
6 months-25.00%
Current year-40.00%
1 week 0.06
Extreme 0.06
0.06
1 month 0.03
Extreme 0.03
0.08
Current year 0.01
Extreme 0.01
0.12
1 year 0.01
Extreme 0.01
0.15
3 years 0.01
Extreme 0.01
0.89
5 years 0.01
Extreme 0.01
0.89
10 years 0
Extreme 0
2.5
Manager TitleAgeSince
Chief Executive Officer - 15/07/2019
Director TitleAgeSince
Chairman 90 15/07/2019
Director/Board Member - 04/10/2011
Chairman 65 16/02/2015
Date Insider Type Main position Quantity % Market Cap.
03/03/26 Option

Chairman

60,000 0.1741%
30/12/25 Option 133,977 0.4201%
29/12/25 Option 90,632 0.2842%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-20.00%-55.56%-89.09% 1.59M
+0.08%-5.49%-12.06%-15.21% 42.91B
-0.12%-3.67%+6.69%+6.36% 23.51B
+2.23%-0.32%-9.69%-29.87% 12.76B
+1.24%-0.19%+15.71%-5.37% 5.43B
-1.11%+2.01%+1.71%-51.76% 3.83B
+0.65%-2.77%+11.45%+22.43% 3.18B
-2.95%-4.24%+2.02%+4.02% 3.09B
-1.79%-2.12%+1.10%+62.62% 1.34B
0.00%-4.09%+2.58%+831.03% 875M
Average -0.18%-2.39%-3.61%+73.52% 9.69B
Weighted average by Cap. +0.23%-3.91%-3.57%-2.24%

Financials

2024 2025
Net sales 1.38K 997.98 855.44 796.28 734.15 95.62K 1.4K 9.41K 3.68K 47.98K 3.75K 3.67K 158K 1.21K 876.4 751.23 699.27 644.71 83.97K 1.23K 8.27K 3.23K 42.14K 3.29K 3.22K 139K
Net income -2.23M -1.61M -1.38M -1.29M -1.19M -154M -2.26M -15.21M -5.95M -77.51M -6.06M -5.93M -255M -2.51M -1.81M -1.55M -1.45M -1.33M -174M -2.55M -17.11M -6.69M -87.19M -6.81M -6.67M -287M
Net Debt 5.54M 4.01M 3.44M 3.2M 2.95M 384M 5.63M 37.85M 14.8M 193M 15.07M 14.75M 635M 6.61M 4.78M 4.1M 3.82M 3.52M 458M 6.72M 45.11M 17.64M 230M 17.97M 17.58M 757M
Logo Biosenta Inc.
Biosenta Inc. is engaged in developing, producing, and manufacturing an array of chemical compounds for household and industrial applications, utilizing advanced encapsulated nanotechnology. It develops antimicrobial products that offer environmentally friendly solutions to a global market. Its flagship product, Tri-Filler, represents an antimicrobial technology, providing durable protection against a wide spectrum of bacteria, molds, and fungi. Tri-filler's Nano-technology particles provide anti-microbial protection while preventing the growth of mold, bacteria and viruses. Tri-filler can be embedded to protect various materials, including drywall, plastic and resin, from microbe formation. These compounds remain active for decades and protect the drywall of buildings, objects such as resin furniture, carpet rubber backing and synthetic tufts containing plastic, resin, textiles and others. Its true disinfectant is recognized by Health Canada for use in the fight against COVID-19.
Employees
-
Date Price Change Volume